NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market on Wednesday that its first-quarter revenues rose five-fold year over year.

The Carlsbad, Calif.-based company reported revenues of $11.1 million for the three months ended March 31, up from $2.2 million in the year-ago period, and beating the consensus Wall Street estimate of $9.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.